Connect Biopharma is trading at $0.93, down 5.06%, on October 2, 2026, with no verified company-specific announcement explaining the decline. - The latest company news was positive preliminary Phase 2 COPD data announced September 30; that earlier news does not establish a reason for this session’s drop. - Major indexes were higher, including the Nasdaq Composite up 1.18%; no clear sector-specific catalyst was identified.